PT - JOURNAL ARTICLE AU - Izquierdo-Lara, Ray AU - Elsinga, Goffe AU - Heijnen, Leo AU - Oude Munnink, Bas B. AU - Schapendonk, Claudia M. E. AU - Nieuwenhuijse, David AU - Kon, Matthijs AU - Lu, Lu AU - Aarestrup, Frank M. AU - Lycett, Samantha AU - Medema, Gertjan AU - Koopmans, Marion P.G. AU - de Graaf, Miranda TI - Monitoring SARS-CoV-2 circulation and diversity through community wastewater sequencing AID - 10.1101/2020.09.21.20198838 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.21.20198838 4099 - http://medrxiv.org/content/early/2020/09/22/2020.09.21.20198838.short 4100 - http://medrxiv.org/content/early/2020/09/22/2020.09.21.20198838.full AB - The current SARS-CoV-2 pandemic has rapidly become a major global health problem for which public health surveillance is crucial to monitor virus spread. Given the presence of viral RNA in feces in around 40% of infected persons, wastewater-based epidemiology has been proposed as an addition to disease-based surveillance to assess the spread of the virus at the community level. Here we have explored the possibility of using next-generation sequencing (NGS) of sewage samples to evaluate the diversity of SARS-CoV-2 at the community level from routine wastewater testing, and compared these results with the virus diversity in patients from the Netherlands and Belgium. Phylogenetic analysis revealed the presence of viruses belonging to the most prevalent clades (19A, 20A and 20B) in both countries. Clades 19B and 20C were not identified, while they were present in clinical samples during the same period. Low frequency variant (LFV) analysis showed that some known LFVs can be associated with particular clusters within a clade, different to those of their consensus sequences, suggesting the presence of at least 2 clades within a single sewage sample. Additionally, combining genome consensus and LFV analyses we found a total of 57 unique mutations in the SARS-CoV-2 genome which have not been described before. In conclusion, this work illustrates how NGS analysis of wastewater can be used to approximate the diversity of SARS-CoV-2 viruses circulating in a community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the European Union’s Horizon 2020 grants VEO (grant nr 874735) and METASTAVA (grant nr 773830), the Erasmus MC foundation and the Adessium Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable. Patient-derived viral sequences were obtained from GISAID database (https://www.gisaid.org/). Our samples were obtained from community wastewaters, which do not require an approval for their use.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesConsensus sequences with coverage >50% were upload to GISAID (https://www.gisaid.org/), accession IDs: EPI_ISL_539300 - EPI_ISL_539325.